✦ LIBER ✦

Combination therapy for osteoporosis: Considerations and controversy

✍ Scribed by Neil Binkley; Diane Krueger

Publisher: Current Science Inc.
Year: 2005
Tongue: English
Weight: 222 KB
Volume: 3
Category: Article
ISSN: 1544-1873
DOI: 10.1007/s11914-996-0018-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy for osteoporosis: Co

Combination therapy for osteoporosis: Considerations and controversy

✍ Neil Binkley; Diane Krueger 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 224 KB

Combination anabolic and antiresorptive

Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window

✍ John P. Bilezikian 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 152 KB

Combination/sequential therapies for ana

Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis

✍ John P. Bilezikian; Mishaela R. Rubin 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 306 KB

Maintenance therapy for NSCLC: Consensus

Maintenance therapy for NSCLC: Consensus and controversy

✍ Shun Lu; Yong-feng Yu 📂 Article 📅 2011 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 512 KB

Theoretical considerations in combinatio

Theoretical considerations in combinations of localized and systemic therapy for neoplastic disease

✍ James J. Fischer; Rose J. Papac 📂 Article 📅 1972 🏛 Elsevier Science 🌐 English ⚖ 613 KB

Three-year calcitonin combination therap

Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine

✍ János Szücs; Csaba Horváth; Éva Kollin; Miklós Szathmári; István Holló 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 449 KB

Forty-five postmenopausal osteoporotic women with at least one osteoporotic vertebral crush fracture were randomized into three treatment groups. Each patient was on calcitonin, 50 U, on alternate days for 2 weeks monthly (350 U/month), and 500 mg/day oral calcium supplementation. In group II, this